Innovative approaches for allogeneic blood and marrow transplantation for treatment of hematological malignancies: Graft engineering and nonmyeloablative preparative regimens

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

I. INTRODUCTION The biological effects of allogeneic hematopoietic transplantation depend on the cellular composition of the graft. Hematopoietic stem and progenitor cells for transplantation can be obtained from bone marrow, mobilized peripheral blood, or cord blood. The goal for patients transplanted for malignancies is to achieve engraftment, develop the immunemediated graft-versus-malignancy effect, whereas avoiding graft-versus-host disease (GVHD). This is a major challenge, since T cells participate in each of these processes and altering the composition of the graft may produce both positive and negative effects. Innovative technology is under evaluation to reduce the alloreactivity of the graft and for the later infusion of immunocompetent cells to enhance immunoreconstitution and graftversus-leukemia (GVL).

Original languageEnglish (US)
Title of host publicationHematopoietic Stem Cell Transplantation
PublisherCRC Press
Pages361-381
Number of pages21
ISBN (Electronic)9780824741815
ISBN (Print)9780824702731
StatePublished - Jan 1 2000

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Innovative approaches for allogeneic blood and marrow transplantation for treatment of hematological malignancies: Graft engineering and nonmyeloablative preparative regimens'. Together they form a unique fingerprint.

Cite this